(Q24244121)

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Arginine supplementation prevents necrotizing enterocolitis in the premature infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

New concepts in necrotizing enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Revisiting ischemia and reperfusion injury as a possible cause of necrotizing enterocolitis: Role of nitric oxide and superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Plasma amino acids in small preterm infants fed on human milk or formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Arginine metabolism: nitric oxide and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Arginine supplementation for prevention of necrotising enterocolitis in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

Role of nitric oxide in gastrointestinal and hepatic function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Mucosal permeability to 51Cr EDTA following subclinical intestinal ischemia-reperfusion injury in the weanling rat

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Use of L-arginine in the treatment of experimental necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Plasma amino acid pattern in normal term breast-fed infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Epidemiology of necrotizing enterocolitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Reduced serum amino acid concentrations in infants with necrotizing enterocolitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Nutrient requirements for preterm infant formulas

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Plasma L-arginine concentration, oxygenation index, and systemic blood pressure in premature infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Arginine deficiency accompanies persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021

Whole body arginine metabolism and nitric oxide synthesis in newborns with persistent pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004339.PUB3

7 January 2021